CO-TRANS-NET Synthetic nucleic acid co-transcriptional networks as diagnostic and therapeutic tools
- Coordinator
- Universita Degli Studi Di Roma Tor Vergata, Italy
- Runs
- 1 January 2025 to 31 December 2029
- Status
- Running
- EU funding
- €1.5m
- Total cost
- €1.5m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101165168
What the project is doing
In the project's own words, from its summary on CORDIS.
WHY: The heterogeneity of tumors often makes their diagnosis and treatment a very hard task. A single tumor can have many different diagnostically-relevant molecular markers which can also be used to monitor the efficacy of treatment. Innovative, simple, cost-effective, and quantitative analytical tools for diagnostic and therapeutic applications are urgently needed to ensure rapid and appropriate patient care. WHAT: CO-TRANS-NET project addresses this need by developing synthetic nucleic acid units that can respond to a wide range of tumor biomarkers and can provide innovative tools for biosensing and therapeutics through cell-free in-vitro transcription.
HOW: The ground-breaking idea of CO-TRANS-NET is to harness the high programmability of synthetic nucleic acids together with the high sensitivity and versatility of cell-free systems to develop co-transcriptional networks that, in one pot, through nature-inspired recognition mechanisms, can respond to a variety of targets including proteins, small molecules and antibodies and trigger in-vitro transcription of functional RNA.
The transcribed RNA can provide a measurable signal or produce a therapeutic drug. CO-TRANS-NET aims to develop single theranostic nanodevices in which cancer diagnosis and theraphy can be simultaneously achieved- This goes beyond the state of the art and represents a breakthrough in the field of diagnostics, biosensing, synthetic biology and nucleic acid-based therapeutics.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universita Degli Studi Di Roma Tor Vergata | Roma | Italy | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI